#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Congenital generalised lipodystrophy Arteriosclerosis Malignant melanoma Anti-neutrophil cytoplasmic antibody positive vasculitis Endometrial cancer recurrent Oesophageal adenocarcinoma stage II Primary adrenal insufficiency Andersen-Tawil syndrome Systemic sclerosis pulmonary Malignant neoplasm of choroid Cholangiosarcoma Pleomorphic leiomyosarcoma Extra-osseous Ewing's sarcoma recurrent Angelman's syndrome Hereditary hypophosphataemic rickets More trials…
Learn about Rare Diseases

Toxic epidermal necrolysis – Diagnostics Cystic fibrosis lung – Basic Information Angiosarcoma non-metastatic – Trials in Disease Cytokine release syndrome Factor IX deficiency – Diagnostics Breast angiosarcoma metastatic – Life with Disease Leukoencephalopathy – Basic Information Pleural mesothelioma malignant – Basic Information Biotinidase deficiency – Life with Disease Proteus syndrome More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Selpercatinib Dorocubicel Gentamicin Sulfate Lenzumestrocel Sodium Ly3484356 Lamivudine Enx-101 O15-Water Meropenem Anhydrous Lenacapavir Sodium Gs-4182 Corylus Avellana L. Azd7798 Proline Neridronate Sodium Ianalumab Antithymocyte Immunoglobulin Ganaxolone Etravirine More therapies…

Learn about Your Condition

Neutropenia Dent's disease Arteriosclerosis Pulmonary embolism Neurofibrosarcoma Encephalitis Japanese B Substance use disorder Food allergy Type 2 diabetes mellitus Peyronie's disease Oral lichen planus Endometrial cancer Brain injury Hodgkin's disease refractory Milk allergy More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

HER2 positive endometrial cancer

Study of Trastuzumab Deruxtecan Versus Chemotherapy as Additional Treatment After Surgery for Patients with HER2-Positive Endometrial Cancer

Recruiting

3 1 1 1
Investigated Drugs:
+1
Study of zanidatamab in adult patients with HER2-positive solid tumors (endometrial, colorectal, head & neck, sarcoma) or HER2-mutant non-small cell lung cancer

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Zanidatamab

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

HER2 positive endometrial cancer

Study of Trastuzumab Deruxtecan Versus Chemotherapy as Additional Treatment After Surgery for Patients with HER2-Positive Endometrial Cancer

Study of zanidatamab in adult patients with HER2-positive solid tumors (endometrial, colorectal, head & neck, sarcoma) or HER2-mutant non-small cell lung cancer

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies